Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG) GlobeNewswire November 05, 2025 Reference is made to the third quarter 2025 report released on November 5, 2025. Golar LNG Limited (“Golar”), NASDAQ ticker: GLNG, has declared a total dividend of $0.25 per share to be paid on or […]
Fleet modernization accelerates as Phenom 300 becomes largest fleet type in revenue serviceand Challenger fleet reaches programmatic scale Newly launched Signature membership delivers industry-leading choice, flexibility and value for premium customers Delta partnership helps drive record corporate Membership Fund sales Productivity initiatives expected to exceed original $50 million goal and drive $70 million or more
Emerson (NYSE:EMR) today reported results1 for its fourth quarter and fiscal year ended September30, 2025. Emerson also declared a 5% quarterly cash dividend increase to$0.555 per share of common stock payable December 10, 2025 to stockholders of record November 14, 2025. Additionally, Emerson announced that its Board of Directors authorized the company to repurchase up
— Q4 sales increased 3% and organic sales increased 4%* — Full year sales increased 3% and organic sales increased 6%* — Q4 GAAP EPS of $0.42; Q4 Adjusted EPS* of $1.26* — Full year GAAP EPS of $2.63; full year Adjusted EPS of $3.76 — Q4 Orders +6% organically year-over-year — Systems and Services
(TSX:BEP.UN),(NYSE:BEP),(NYSE:BEPC),(TSX:BEP-UN),(TSX:BEPC), All amounts in U.S. dollars unless otherwise indicated BROOKFIELD, News, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable Partners“, “BEP“) today reported financial results for the three and nine months ended September 30, 2025. “We had another strong quarter, advancing several strategic priorities while delivering strong
(NASDAQ:CMND),(Frankfurt:CWY0), Patent expands MEAI's global intellectual property protection as Clearmind advances clinical development and commercialization plans Vancouver, Canada, Nov. 05, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, today
CHICAGO and MILWAUKEE and NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) — YieldMax(R) ETFs today announced distributions for the YieldMax(R) Group 2 weekly pay ETFs. Group 2 Distribution Announcement Ex. & Record Date: November 6, 2025 Payment Date: November 7, 2025 ETF Ticker1 ETF Name DistributionFrequency Distribution perShare DistributionRate2,4 30-DaySEC Yield3 ROC5 ABNY YieldMax(R) ABNB
(TSX:SJ), MONTREAL, Nov. 05, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or the “Company”) announced today that the Toronto Stock Exchange (“TSX”) has accepted its Notice of Intention to Make a Normal Course Issuer Bid (the “Notice”). Pursuant to the Notice, Stella-Jones may, during the 12-month period commencing November 14, 2025, and ending
Brookfield Renewable Reports Third Quarter Results GlobeNewswire November 05, 2025 All amounts in U.S. dollars unless otherwise indicated BROOKFIELD, News, Nov. 05, 2025 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) (“Brookfield Renewable Partners“, “BEP“) today reported financial results for the three and nine months ended September 30, 2025. “We had another
Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing GlobeNewswire November 05, 2025 Patent expands MEAI's global intellectual property protection as Clearmind advances clinical development and commercialization plans Vancouver, Canada, Nov. 05, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a